A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2015; you can also visit the original URL.
The file type is
Myeloma Proteins and the Clinical Response to Melphalan Therapy
Objective improvement after therapy with melphalan occurred in all patients producing only Bence Jones kappa proteins, in half of the patients with myeloma serum proteins, and in none of those producing only Bence Jones lambda proteins.doi:10.1126/science.148.3668.376 pmid:14261530 fatcat:fwzrswohzbbblnqkvuplzoix7a